The prescription drugs market size is projected to reach US$ 2,350.12 billion by 2031 from US$ 1,440.79 billion in 2024. The market is expected to register a CAGR of 7.3% during 2025–2031. The growth of personalized and precision medicine is likely to bring new trends in the prescription drugs market in the coming years.
Prescription Drugs Market Analysis
The increasing prevalence of chronic disorders and the rising development and adoption of innovative and specialty drugs boost the prescription drugs market. Additionally, increasing awareness of various conditions and the development of new drugs are expected to contribute to market growth in the near future. Moreover, new product developments, launches, approvals, and expansions are expected to create ample opportunities in the coming years.
Prescription Drugs Market Overview
North America is projected to dominate the prescription drugs market with the largest share during the forecast period. Further, Asia Pacific is expected to register a significant CAGR owing to the aging population, which increases the demand for chronic disease management and long-term medication use. With rising incidences of lifestyle-related diseases, the need for effective prescription drugs has surged. Additionally, improving healthcare infrastructure and increasing access to medical facilities in developing countries such as India, China, and Southeast Asian nations have expanded the reach of prescription medications to previously underserved populations. Rising disposable incomes and expanding middle-class populations have improved affordability and willingness to spend on healthcare, including prescription drugs. Governments in Asia Pacific have prioritized healthcare reforms and increased healthcare expenditure, encouraging better insurance coverage and reimbursement policies that support pharmaceutical consumption.
Technological advancements and the growth of pharmaceutical research and development have led to the innovation of targeted therapies, attracting more patients and physicians to prescribed medicines. The growing awareness and adoption of modern healthcare practices, coupled with urbanization and lifestyle changes, have further contributed to the increased demand for prescription drugs. Moreover, the rise of digital health platforms and telemedicine has improved patient access to healthcare providers, facilitating better diagnosis and prescription compliance.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Prescription Drugs Market: Strategic Insights
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Prescription Drugs Market: Strategic Insights
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Prescription Drugs Market Drivers and Opportunities
Increasing Prevalence of Chronic Disorders
The increasing aging population and changing lifestyle contribute to a few common long-term health conditions. As per the World Health Organization (WHO), the prevalence of chronic lifestyle diseases is expected to increase by 57% by the end of 2026. With the increasing urbanization, people are more inclined toward a sedentary lifestyle, which results in rheumatoid arthritis, diabetes, and other disorders. Diabetes is one of the major global health issues of the 21st century. According to the International Diabetes Federation (IDF), there were 589 million adults living with diabetes globally in 2024, and it is expected to reach 853 million by the end of 2050. The increase in disease prevalence is expected to be 35% during the forecast period.
Other chronic conditions, such as multiple sclerosis, Crohn’s disease, neurological disorders, and cardiovascular disorders, require various drugs for the long-term management of the chronic conditions. As per the WHO, cardiovascular disorders are one of the leading causes of death, accounting for 17.9 million deaths worldwide every year. Moreover, the nature of chronic diseases often requires the use of multiple medications and advanced therapies, including biologics and specialty drugs that are sold on prescription, which are typically more expensive and generate higher revenues for pharmaceutical companies. Additionally, the development of new treatments is incentivized by the unmet clinical needs of patients with rare diseases, leading to increased investment in research and development by major pharmaceutical firms. Therefore, the increasing prevalence of chronic disorders and unmet clinical needs drives the prescription drugs market.
Strategic Initiatives by Market Players Create Ample Opportunities for Market Growth
Various players in the prescription drugs market focus on product approvals, launches, and strategic collaborations to develop effective products required to treat and manage chronic disorders. Subsequently, several recent developments have taken place in the prescription drugs market. A few are mentioned below:
- In May 2025, Bio-Thera Solutions, Ltd. received FDA approval for Starjemza Injection. It is a human interleukin-12 and -23 antagonist interchangeable biosimilar to Stelara, used to treat Crohn's disease, plaque psoriasis, ulcerative colitis, and psoriatic arthritis.
- In November 2024, Sunshine Biopharma Inc. launched a new generic prescription drug called Ursodiol, also known as ursodeoxycholic acid (UDCA). It is indicated for the management of cholestatic liver diseases, including primary biliary cirrhosis (PBC).
- In June 2024, Teva launched an authorized generic of Victoza (liraglutide injection 1.8 mg) in the US. It is recommended to improve glycemic control in adults and pediatric patients aged 10 years and older living with type 2 diabetes mellitus; it also reduces the risk of cardiovascular events in type 2 diabetes patients.
- In April 2024, ImmunityBio, Inc. received FDA approval for ANKTIVA plus Bacillus Calmette-Guérin (BCG) for the treatment of patients with BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) with carcinoma in situ (CIS), with or without papillary tumors.
- In October 2022, Pfizer Inc. completed the acquisition of Biohaven Pharmaceutical Holding Company Ltd to add a breakthrough calcitonin gene-related peptide portfolio, including NURTEC ODT, to address the needs of migraine patients worldwide.
- In January 2022, Cosette Pharmaceuticals acquired US sales and distribution rights to eight prescription medications from Daiichi Sankyo Company and its affiliates. The products include Benicar, Benicar HCT, Azor, Tribenzor, Welchol, Welchol Oral Suspension, Effient, and Evoxac.
Therefore, increasing product launches, approvals, and strategic collaborations are expected to create ample opportunities for the growth of the prescription drugs market in the coming years.
Prescription Drugs Market Report Segmentation Analysis
Key segments that form the foundation of the prescription drugs market analysis are product type, drug type, route of administration, therapeutic area, and distribution channel.
- Based on product type, the prescription drugs market is bifurcated into branded and generics. The branded segment held a larger market share in 2024 and is expected to register a higher CAGR during 2025–2031.
- By drug type, the prescription drugs market is bifurcated into small molecule and biologics and biosimilar. The small molecule segment held a larger share of the market in 2024. The biologics and biosimilar segment is expected to register a higher CAGR in the market during 2025–2031.
- In terms of therapeutic area, the prescription drugs market is segmented into oncology, cardiovascular diseases, neurological diseases, metabolic diseases, respiratory diseases, immunology, and others. The oncology segment dominated the market in 2024 and is anticipated to register the highest CAGR during 2025–2031.
- By route of administration, the prescription drugs market is segmented into oral, injectable, topical, and others. The oral segment held the largest share of the market in 2024, and is expected to register the highest CAGR in the market during 2025–2031.
- In terms of distribution channel, the prescription drugs market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies. The hospital pharmacies segment dominated the market in 2024 and is anticipated to register the highest CAGR during 2025–2031.
Prescription Drugs Market Share Analysis by Geography
The geographical scope of the prescription drugs market report is mainly divided into five regions: North America, Asia Pacific, Europe, and Middle East & Africa, and South & Central America. North America held a significant share of the market in 2024. The prescription drugs market in North America is driven by the aging population. As the baby boomer generation grows older, the prevalence of chronic diseases such as diabetes, cardiovascular disorders, and cancer has increased, thereby boosting the demand for prescription medications.
Advancements in pharmaceutical research and biotechnology have also played a critical role. Innovations in drug development, including biologics and personalized medicine, have expanded treatment options, enhancing efficacy and safety. The introduction of novel therapies for previously untreatable conditions propelled the market growth.
Another major contributor is the strong healthcare infrastructure in North America, supported by substantial investments in healthcare facilities, insurance coverage, and pharmaceutical distribution networks. The widespread availability of healthcare services and better patient awareness about disease management have increased prescription drug consumption. Additionally, regulatory support from agencies such as the US Food and Drug Administration (FDA) facilitates quicker approval processes for innovative drugs, enabling faster market entry. Furthermore, government initiatives aimed at expanding healthcare coverage, such as the Affordable Care Act in the US, have increased access to prescription drugs for a broader population.
Also, the rise in lifestyle-related diseases and increased prevalence of mental health disorders have created a sustained demand for therapeutic drugs. The COVID-19 pandemic also emphasized the importance of pharmaceutical interventions, accelerating investments in drug development and distribution.
Prescription Drugs Market Report Scope
Prescription Drugs Market News and Recent Developments
The prescription drugs market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the developments in the market are listed below:
- ESTEVE plans to invest 100 million euros in a new manufacturing plant at its Celrà industrial center in Girona, aiming for completion by 2026. The expansion will enhance the production capacity for active pharmaceutical ingredients and add ~100 new jobs, raising the workforce to ~470. The project includes new production and service buildings, with the installation of 150 cubic meters of reaction volume, resulting in a 45% increase in production capacity at Celrà and a 15% boost in the company’s overall capacity. (Source: ESTEVE, Company Website, June 2025)
- Roche will invest US$ 50 billion in the US in the next five years. These investments further strengthen Roche’s significant US footprint with 13 manufacturing and 15 research and development sites across the Pharmaceutical and Diagnostics Divisions, and are expected to create more than 12,000 new jobs, including ~6,500 construction jobs, as well as 1,000 jobs at new and expanded facilities. (Source: F. Hoffmann-La Roche Ltd , Company Website, April 2025)
- Pfizer Inc. received the U.S. Food and Drug Administration (FDA) approval for the supplemental Biologics License Application (sBLA) for ADCETRIS (brentuximab vedotin) in combination with lenalidomide and a rituximab product. This treatment is for adult patients with relapsed or refractory large B-cell lymphoma (LBCL), including various forms of diffuse large B-cell lymphoma (DLBCL), following two or more lines of systemic therapy. It is intended for those who are not eligible for autologous hematopoietic stem cell transplantation (auto-HSCT) or CAR T-cell therapy. (Source: Pfizer Inc., Company Website, February 2025)
Prescription Drugs Market Report Coverage and Deliverables
The “Prescription Drugs Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:
- Prescription drugs market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Prescription drugs market trends, as well as market dynamics such as drivers, restraints, and key opportunities
- Detailed PEST and SWOT analysis
- Prescription drugs market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments
- Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the prescription drugs market
- Detailed company profiles
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The prescription drugs market is estimated to register a CAGR of 7.3% during the forecast period.
The prescription drugs market is estimated to reach a value of US$ 2,350.12 billion by 2031.
Johnson & Johnson; Pfizer Inc; Merck & Co Inc; Eli Lilly and Co; ESTEVE; AstraZeneca Plc; Sanofi SA; GSK Plc; F. Hoffmann-La Roche; Novartis AG; AbbVie Inc; Teva Pharmaceutical Industries Ltd are among the key players operating in the prescription drugs market.
North America dominated the market in 2024.
The increasing prevalence of chronic disorders and the increasing development and adoption of innovative and specialty drugs are the most influential factors responsible for the market growth.
1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Analyst Market Outlook
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:
3.3 Assumptions and Limitations
4. Prescription Drugs Market Landscape
4.1 Overview
4.2 PEST Analysis
5. Prescription Drugs Market – Key Market Dynamics
5.1 Prescription Drugs Market – Key Market Dynamics
5.2 Market Drivers:
5.2.1 Increasing Prevalence of Chronic Disorders
5.2.2 Development and Adoption of Innovative and Specialty Drugs
5.3 Market Restraints
5.3.1 High Drug Prices and Affordability Issues
5.4 Market Opportunities
5.4.1 Strategic Initiatives by Market Players
5.5 Future Trends
5.5.1 Growth of Personalized and Precision Medicine
5.6 Impact of Drivers and Restraints:
6. Prescription Drugs Market – Global Market Analysis
6.1 Prescription Drugs Market Revenue (US$ Billion), 2021–2031
6.2 Prescription Drugs Market Forecast Analysis
7. Prescription Drugs Market Analysis – by Product Type
7.1 Branded
7.1.1 Overview
7.1.2 Branded: Prescription Drugs Market – Revenue and Forecast to 2031 (US$ Billion)
7.2 Generics
7.2.1 Overview
7.2.2 Generics: Prescription Drugs Market – Revenue and Forecast to 2031 (US$ Billion)
8. Prescription Drugs Market Analysis – by Drug Type
8.1 Small Molecule
8.1.1 Overview
8.1.2 Small Molecule: Prescription Drugs Market – Revenue and Forecast to 2031 (US$ Billion)
8.2 Biologics and Biosimilar
8.2.1 Overview
8.2.2 Biologics and Biosimilar: Prescription Drugs Market – Revenue and Forecast to 2031 (US$ Billion)
9. Prescription Drugs Market Analysis – by Therapeutic Area
9.1 Oncology
9.1.1 Overview
9.1.2 Oncology: Prescription Drugs Market – Revenue and Forecast to 2031 (US$ Billion)
9.2 Cardiovascular Diseases
9.2.1 Overview
9.2.2 Cardiovascular Diseases: Prescription Drugs Market – Revenue and Forecast to 2031 (US$ Billion)
9.3 Neurological Diseases
9.3.1 Overview
9.3.2 Neurological Diseases: Prescription Drugs Market – Revenue and Forecast to 2031 (US$ Billion)
9.4 Metabolic Diseases
9.4.1 Overview
9.4.2 Metabolic Diseases: Prescription Drugs Market – Revenue and Forecast to 2031 (US$ Billion)
9.5 Respiratory Diseases
9.5.1 Overview
9.5.2 Respiratory Diseases: Prescription Drugs Market – Revenue and Forecast to 2031 (US$ Billion)
9.6 Immunology
9.6.1 Overview
9.6.2 Immunology: Prescription Drugs Market – Revenue and Forecast to 2031 (US$ Billion)
9.7 Others
9.7.1 Overview
9.7.2 Others: Prescription Drugs Market – Revenue and Forecast to 2031 (US$ Billion)
10. Prescription Drugs Market Analysis – by Route Of Administration
10.1 Oral
10.1.1 Overview
10.1.2 Oral: Prescription Drugs Market – Revenue and Forecast to 2031 (US$ Billion)
10.2 Injectable
10.2.1 Overview
10.2.2 Injectable: Prescription Drugs Market – Revenue and Forecast to 2031 (US$ Billion)
10.3 Topical
10.3.1 Overview
10.3.2 Topical: Prescription Drugs Market – Revenue and Forecast to 2031 (US$ Billion)
10.4 Others
10.4.1 Overview
10.4.2 Others: Prescription Drugs Market – Revenue and Forecast to 2031 (US$ Billion)
11. Prescription Drugs Market Analysis – by Distribution Channel
11.1 Hospital Pharmacies
11.1.1 Overview
11.1.2 Hospital Pharmacies: Prescription Drugs Market – Revenue and Forecast to 2031 (US$ Billion)
11.2 Retail Pharmacies
11.2.1 Overview
11.2.2 Retail Pharmacies: Prescription Drugs Market – Revenue and Forecast to 2031 (US$ Billion)
11.3 Online Pharmacies
11.3.1 Overview
11.3.2 Online Pharmacies: Prescription Drugs Market – Revenue and Forecast to 2031 (US$ Billion)
12. Prescription Drugs Market – Geographical Analysis
12.1 North America
12.1.1 North America Prescription Drugs Market Overview
12.1.2 North America: Prescription Drugs Market – Revenue, 2021–2031 (US$ Billion)
12.1.2.1 North America: Prescription Drugs Market – Revenue and Forecast Analysis – by Product Type
12.1.2.2 North America: Prescription Drugs Market – Revenue and Forecast Analysis – by Drug Type
12.1.2.3 North America: Prescription Drugs Market – Revenue and Forecast Analysis – by Therapeutic Area
12.1.2.4 North America: Prescription Drugs Market – Revenue and Forecast Analysis – by Route Of Administration
12.1.2.5 North America: Prescription Drugs Market – Revenue and Forecast Analysis – by Distribution Channel
12.1.3 North America: Prescription Drugs Market – Revenue and Forecast Analysis – by Country
12.1.3.1 United States: Prescription Drugs Market – Revenue and Forecast, 2021–2031 (US$ Billion)
12.1.3.1.1 United States: Prescription Drugs Market Breakdown, by Product Type
12.1.3.1.2 United States: Prescription Drugs Market Breakdown, by Drug Type
12.1.3.1.3 United States: Prescription Drugs Market Breakdown, by Therapeutic Area
12.1.3.1.4 United States: Prescription Drugs Market Breakdown, by Route Of Administration
12.1.3.1.5 United States: Prescription Drugs Market Breakdown, by Distribution Channel
12.1.3.2 Canada: Prescription Drugs Market – Revenue and Forecast, 2021–2031 (US$ Billion)
12.1.3.2.1 Canada: Prescription Drugs Market Breakdown, by Product Type
12.1.3.2.2 Canada: Prescription Drugs Market Breakdown, by Drug Type
12.1.3.2.3 Canada: Prescription Drugs Market Breakdown, by Therapeutic Area
12.1.3.2.4 Canada: Prescription Drugs Market Breakdown, by Route Of Administration
12.1.3.2.5 Canada: Prescription Drugs Market Breakdown, by Distribution Channel
12.1.3.3 Mexico: Prescription Drugs Market – Revenue and Forecast, 2021–2031 (US$ Billion)
12.1.3.3.1 Mexico: Prescription Drugs Market Breakdown, by Product Type
12.1.3.3.2 Mexico: Prescription Drugs Market Breakdown, by Drug Type
12.1.3.3.3 Mexico: Prescription Drugs Market Breakdown, by Therapeutic Area
12.1.3.3.4 Mexico: Prescription Drugs Market Breakdown, by Route Of Administration
12.1.3.3.5 Mexico: Prescription Drugs Market Breakdown, by Distribution Channel
12.2 Europe
12.2.1 Europe Prescription Drugs Market Overview
12.2.2 Europe: Prescription Drugs Market – Revenue, 2021–2031 (US$ Billion)
12.2.2.1 Europe: Prescription Drugs Market – Revenue and Forecast Analysis – by Product Type
12.2.2.2 Europe: Prescription Drugs Market – Revenue and Forecast Analysis – by Drug Type
12.2.2.3 Europe: Prescription Drugs Market – Revenue and Forecast Analysis – by Therapeutic Area
12.2.2.4 Europe: Prescription Drugs Market – Revenue and Forecast Analysis – by Route Of Administration
12.2.2.5 Europe: Prescription Drugs Market – Revenue and Forecast Analysis – by Distribution Channel
12.2.3 Europe: Prescription Drugs Market – Revenue and Forecast Analysis – by Country
12.2.3.1 Germany: Prescription Drugs Market – Revenue and Forecast, 2021–2031 (US$ Billion)
12.2.3.1.1 Germany: Prescription Drugs Market Breakdown, by Product Type
12.2.3.1.2 Germany: Prescription Drugs Market Breakdown, by Drug Type
12.2.3.1.3 Germany: Prescription Drugs Market Breakdown, by Therapeutic Area
12.2.3.1.4 Germany: Prescription Drugs Market Breakdown, by Route Of Administration
12.2.3.1.5 Germany: Prescription Drugs Market Breakdown, by Distribution Channel
12.2.3.2 United Kingdom: Prescription Drugs Market – Revenue and Forecast, 2021–2031 (US$ Billion)
12.2.3.2.1 United Kingdom: Prescription Drugs Market Breakdown, by Product Type
12.2.3.2.2 United Kingdom: Prescription Drugs Market Breakdown, by Drug Type
12.2.3.2.3 United Kingdom: Prescription Drugs Market Breakdown, by Therapeutic Area
12.2.3.2.4 United Kingdom: Prescription Drugs Market Breakdown, by Route Of Administration
12.2.3.2.5 United Kingdom: Prescription Drugs Market Breakdown, by Distribution Channel
12.2.3.3 France: Prescription Drugs Market – Revenue and Forecast, 2021–2031 (US$ Billion)
12.2.3.3.1 France: Prescription Drugs Market Breakdown, by Product Type
12.2.3.3.2 France: Prescription Drugs Market Breakdown, by Drug Type
12.2.3.3.3 France: Prescription Drugs Market Breakdown, by Therapeutic Area
12.2.3.3.4 France: Prescription Drugs Market Breakdown, by Route Of Administration
12.2.3.3.5 France: Prescription Drugs Market Breakdown, by Distribution Channel
12.2.3.4 Italy: Prescription Drugs Market – Revenue and Forecast, 2021–2031 (US$ Billion)
12.2.3.4.1 Italy: Prescription Drugs Market Breakdown, by Product Type
12.2.3.4.2 Italy: Prescription Drugs Market Breakdown, by Drug Type
12.2.3.4.3 Italy: Prescription Drugs Market Breakdown, by Therapeutic Area
12.2.3.4.4 Italy: Prescription Drugs Market Breakdown, by Route Of Administration
12.2.3.4.5 Italy: Prescription Drugs Market Breakdown, by Distribution Channel
12.2.3.5 Spain: Prescription Drugs Market – Revenue and Forecast, 2021–2031 (US$ Billion)
12.2.3.5.1 Spain: Prescription Drugs Market Breakdown, by Product Type
12.2.3.5.2 Spain: Prescription Drugs Market Breakdown, by Drug Type
12.2.3.5.3 Spain: Prescription Drugs Market Breakdown, by Therapeutic Area
12.2.3.5.4 Spain: Prescription Drugs Market Breakdown, by Route Of Administration
12.2.3.5.5 Spain: Prescription Drugs Market Breakdown, by Distribution Channel
12.2.3.6 Rest of Europe: Prescription Drugs Market – Revenue and Forecast, 2021–2031 (US$ Billion)
12.2.3.6.1 Rest of Europe: Prescription Drugs Market Breakdown, by Product Type
12.2.3.6.2 Rest of Europe: Prescription Drugs Market Breakdown, by Drug Type
12.2.3.6.3 Rest of Europe: Prescription Drugs Market Breakdown, by Therapeutic Area
12.2.3.6.4 Rest of Europe: Prescription Drugs Market Breakdown, by Route Of Administration
12.2.3.6.5 Rest of Europe: Prescription Drugs Market Breakdown, by Distribution Channel
12.3 Asia Pacific
12.3.1 Asia Pacific Prescription Drugs Market Overview
12.3.2 Asia Pacific: Prescription Drugs Market – Revenue, 2021–2031 (US$ Billion)
12.3.2.1 Asia Pacific: Prescription Drugs Market – Revenue and Forecast Analysis – by Product Type
12.3.2.2 Asia Pacific: Prescription Drugs Market – Revenue and Forecast Analysis – by Drug Type
12.3.2.3 Asia Pacific: Prescription Drugs Market – Revenue and Forecast Analysis – by Therapeutic Area
12.3.2.4 Asia Pacific: Prescription Drugs Market – Revenue and Forecast Analysis – by Route Of Administration
12.3.2.5 Asia Pacific: Prescription Drugs Market – Revenue and Forecast Analysis – by Distribution Channel
12.3.3 Asia Pacific: Prescription Drugs Market – Revenue and Forecast Analysis – by Country
12.3.3.1 China: Prescription Drugs Market – Revenue and Forecast, 2021–2031 (US$ Billion)
12.3.3.1.1 China: Prescription Drugs Market Breakdown, by Product Type
12.3.3.1.2 China: Prescription Drugs Market Breakdown, by Drug Type
12.3.3.1.3 China: Prescription Drugs Market Breakdown, by Therapeutic Area
12.3.3.1.4 China: Prescription Drugs Market Breakdown, by Route Of Administration
12.3.3.1.5 China: Prescription Drugs Market Breakdown, by Distribution Channel
12.3.3.2 Japan: Prescription Drugs Market – Revenue and Forecast, 2021–2031 (US$ Billion)
12.3.3.2.1 Japan: Prescription Drugs Market Breakdown, by Product Type
12.3.3.2.2 Japan: Prescription Drugs Market Breakdown, by Drug Type
12.3.3.2.3 Japan: Prescription Drugs Market Breakdown, by Therapeutic Area
12.3.3.2.4 Japan: Prescription Drugs Market Breakdown, by Route Of Administration
12.3.3.2.5 Japan: Prescription Drugs Market Breakdown, by Distribution Channel
12.3.3.3 India: Prescription Drugs Market – Revenue and Forecast, 2021–2031 (US$ Billion)
12.3.3.3.1 India: Prescription Drugs Market Breakdown, by Product Type
12.3.3.3.2 India: Prescription Drugs Market Breakdown, by Drug Type
12.3.3.3.3 India: Prescription Drugs Market Breakdown, by Therapeutic Area
12.3.3.3.4 India: Prescription Drugs Market Breakdown, by Route Of Administration
12.3.3.3.5 India: Prescription Drugs Market Breakdown, by Distribution Channel
12.3.3.4 Australia: Prescription Drugs Market – Revenue and Forecast, 2021–2031 (US$ Billion)
12.3.3.4.1 Australia: Prescription Drugs Market Breakdown, by Product Type
12.3.3.4.2 Australia: Prescription Drugs Market Breakdown, by Drug Type
12.3.3.4.3 Australia: Prescription Drugs Market Breakdown, by Therapeutic Area
12.3.3.4.4 Australia: Prescription Drugs Market Breakdown, by Route Of Administration
12.3.3.4.5 Australia: Prescription Drugs Market Breakdown, by Distribution Channel
12.3.3.5 South Korea: Prescription Drugs Market – Revenue and Forecast, 2021–2031 (US$ Billion)
12.3.3.5.1 South Korea: Prescription Drugs Market Breakdown, by Product Type
12.3.3.5.2 South Korea: Prescription Drugs Market Breakdown, by Drug Type
12.3.3.5.3 South Korea: Prescription Drugs Market Breakdown, by Therapeutic Area
12.3.3.5.4 South Korea: Prescription Drugs Market Breakdown, by Route Of Administration
12.3.3.5.5 South Korea: Prescription Drugs Market Breakdown, by Distribution Channel
12.3.3.6 Rest of APAC: Prescription Drugs Market – Revenue and Forecast, 2021–2031 (US$ Billion)
12.3.3.6.1 Rest of APAC: Prescription Drugs Market Breakdown, by Product Type
12.3.3.6.2 Rest of APAC: Prescription Drugs Market Breakdown, by Drug Type
12.3.3.6.3 Rest of APAC: Prescription Drugs Market Breakdown, by Therapeutic Area
12.3.3.6.4 Rest of APAC: Prescription Drugs Market Breakdown, by Route Of Administration
12.3.3.6.5 Rest of APAC: Prescription Drugs Market Breakdown, by Distribution Channel
12.4 Middle East and Africa
12.4.1 Middle East and Africa Prescription Drugs Market Overview
12.4.2 Middle East and Africa: Prescription Drugs Market – Revenue, 2021–2031 (US$ Billion)
12.4.2.1 Middle East and Africa: Prescription Drugs Market – Revenue and Forecast Analysis – by Product Type
12.4.2.2 Middle East and Africa: Prescription Drugs Market – Revenue and Forecast Analysis – by Drug Type
12.4.2.3 Middle East and Africa: Prescription Drugs Market – Revenue and Forecast Analysis – by Therapeutic Area
12.4.2.4 Middle East and Africa: Prescription Drugs Market – Revenue and Forecast Analysis – by Route Of Administration
12.4.2.5 Middle East and Africa: Prescription Drugs Market – Revenue and Forecast Analysis – by Distribution Channel
12.4.3 Middle East and Africa: Prescription Drugs Market – Revenue and Forecast Analysis – by Country
12.4.3.1 Saudi Arabia: Prescription Drugs Market – Revenue and Forecast, 2021–2031 (US$ Billion)
12.4.3.1.1 Saudi Arabia: Prescription Drugs Market Breakdown, by Product Type
12.4.3.1.2 Saudi Arabia: Prescription Drugs Market Breakdown, by Drug Type
12.4.3.1.3 Saudi Arabia: Prescription Drugs Market Breakdown, by Therapeutic Area
12.4.3.1.4 Saudi Arabia: Prescription Drugs Market Breakdown, by Route Of Administration
12.4.3.1.5 Saudi Arabia: Prescription Drugs Market Breakdown, by Distribution Channel
12.4.3.2 South Africa: Prescription Drugs Market – Revenue and Forecast, 2021–2031 (US$ Billion)
12.4.3.2.1 South Africa: Prescription Drugs Market Breakdown, by Product Type
12.4.3.2.2 South Africa: Prescription Drugs Market Breakdown, by Drug Type
12.4.3.2.3 South Africa: Prescription Drugs Market Breakdown, by Therapeutic Area
12.4.3.2.4 South Africa: Prescription Drugs Market Breakdown, by Route Of Administration
12.4.3.2.5 South Africa: Prescription Drugs Market Breakdown, by Distribution Channel
12.4.3.3 United Arab Emirates: Prescription Drugs Market – Revenue and Forecast, 2021–2031 (US$ Billion)
12.4.3.3.1 United Arab Emirates: Prescription Drugs Market Breakdown, by Product Type
12.4.3.3.2 United Arab Emirates: Prescription Drugs Market Breakdown, by Drug Type
12.4.3.3.3 United Arab Emirates: Prescription Drugs Market Breakdown, by Therapeutic Area
12.4.3.3.4 United Arab Emirates: Prescription Drugs Market Breakdown, by Route Of Administration
12.4.3.3.5 United Arab Emirates: Prescription Drugs Market Breakdown, by Distribution Channel
12.4.3.4 Rest of Middle East and Africa: Prescription Drugs Market – Revenue and Forecast, 2021–2031 (US$ Billion)
12.4.3.4.1 Rest of Middle East and Africa: Prescription Drugs Market Breakdown, by Product Type
12.4.3.4.2 Rest of Middle East and Africa: Prescription Drugs Market Breakdown, by Drug Type
12.4.3.4.3 Rest of Middle East and Africa: Prescription Drugs Market Breakdown, by Therapeutic Area
12.4.3.4.4 Rest of Middle East and Africa: Prescription Drugs Market Breakdown, by Route Of Administration
12.4.3.4.5 Rest of Middle East and Africa: Prescription Drugs Market Breakdown, by Distribution Channel
12.5 South and Central America
12.5.1 South and Central America Prescription Drugs Market Overview
12.5.2 South and Central America: Prescription Drugs Market – Revenue, 2021–2031 (US$ Billion)
12.5.2.1 South and Central America: Prescription Drugs Market – Revenue and Forecast Analysis – by Product Type
12.5.2.2 South and Central America: Prescription Drugs Market – Revenue and Forecast Analysis – by Drug Type
12.5.2.3 South and Central America: Prescription Drugs Market – Revenue and Forecast Analysis – by Therapeutic Area
12.5.2.4 South and Central America: Prescription Drugs Market – Revenue and Forecast Analysis – by Route Of Administration
12.5.2.5 South and Central America: Prescription Drugs Market – Revenue and Forecast Analysis – by Distribution Channel
12.5.3 South and Central America: Prescription Drugs Market – Revenue and Forecast Analysis – by Country
12.5.3.1 Brazil: Prescription Drugs Market – Revenue and Forecast, 2021–2031 (US$ Billion)
12.5.3.1.1 Brazil: Prescription Drugs Market Breakdown, by Product Type
12.5.3.1.2 Brazil: Prescription Drugs Market Breakdown, by Drug Type
12.5.3.1.3 Brazil: Prescription Drugs Market Breakdown, by Therapeutic Area
12.5.3.1.4 Brazil: Prescription Drugs Market Breakdown, by Route Of Administration
12.5.3.1.5 Brazil: Prescription Drugs Market Breakdown, by Distribution Channel
12.5.3.2 Argentina: Prescription Drugs Market – Revenue and Forecast, 2021–2031 (US$ Billion)
12.5.3.2.1 Argentina: Prescription Drugs Market Breakdown, by Product Type
12.5.3.2.2 Argentina: Prescription Drugs Market Breakdown, by Drug Type
12.5.3.2.3 Argentina: Prescription Drugs Market Breakdown, by Therapeutic Area
12.5.3.2.4 Argentina: Prescription Drugs Market Breakdown, by Route Of Administration
12.5.3.2.5 Argentina: Prescription Drugs Market Breakdown, by Distribution Channel
12.5.3.3 Rest of South and Central America: Prescription Drugs Market – Revenue and Forecast, 2021–2031 (US$ Billion)
12.5.3.3.1 Rest of South and Central America: Prescription Drugs Market Breakdown, by Product Type
12.5.3.3.2 Rest of South and Central America: Prescription Drugs Market Breakdown, by Drug Type
12.5.3.3.3 Rest of South and Central America: Prescription Drugs Market Breakdown, by Therapeutic Area
12.5.3.3.4 Rest of South and Central America: Prescription Drugs Market Breakdown, by Route Of Administration
12.5.3.3.5 Rest of South and Central America: Prescription Drugs Market Breakdown, by Distribution Channel
13. Competitive Landscape
13.1 Heat Map Analysis by Key Players
13.2 Company Positioning & Concentration
14. Industry Landscape
14.1 Overview
14.2 Growth Strategies in the Prescription Drugs Market
14.3 Organic Growth Strategies
14.3.1 Overview
14.4 Inorganic Growth Strategies
14.4.1 Overview
15. Company Profiles
15.1 Johnson & Johnson
15.1.1 Key Facts
15.1.2 Business Description
15.1.3 Products and Services
15.1.4 Financial Overview
15.1.5 SWOT Analysis
15.1.6 Key Developments
15.2 Pfizer Inc
15.2.1 Key Facts
15.2.2 Business Description
15.2.3 Products and Services
15.2.4 Financial Overview
15.2.5 SWOT Analysis
15.2.6 Key Developments
15.3 Merck & Co Inc
15.3.1 Key Facts
15.3.2 Business Description
15.3.3 Products and Services
15.3.4 Financial Overview
15.3.5 SWOT Analysis
15.3.6 Key Developments
15.4 Eli Lilly and Co
15.4.1 Key Facts
15.4.2 Business Description
15.4.3 Products and Services
15.4.4 Financial Overview
15.4.5 SWOT Analysis
15.4.6 Key Developments
15.5 ESTEVE
15.5.1 Key Facts
15.5.2 Business Description
15.5.3 Products and Services
15.5.4 Financial Overview
15.5.5 SWOT Analysis
15.5.6 Key Developments
15.6 AstraZeneca Plc
15.6.1 Key Facts
15.6.2 Business Description
15.6.3 Products and Services
15.6.4 Financial Overview
15.6.5 SWOT Analysis
15.6.6 Key Developments
15.7 Sanofi SA
15.7.1 Key Facts
15.7.2 Business Description
15.7.3 Products and Services
15.7.4 Financial Overview
15.7.5 SWOT Analysis
15.7.6 Key Developments
15.8 GSK Plc
15.8.1 Key Facts
15.8.2 Business Description
15.8.3 Products and Services
15.8.4 Financial Overview
15.8.5 SWOT Analysis
15.8.6 Key Developments
15.9 F. Hoffmann-La Roche Ltd
15.9.1 Key Facts
15.9.2 Business Description
15.9.3 Products and Services
15.9.4 Financial Overview
15.9.5 SWOT Analysis
15.9.6 Key Developments
15.10 Novartis AG
15.10.1 Key Facts
15.10.2 Business Description
15.10.3 Products and Services
15.10.4 Financial Overview
15.10.5 SWOT Analysis
15.10.6 Key Developments
15.11 AbbVie Inc
15.11.1 Key Facts
15.11.2 Business Description
15.11.3 Products and Services
15.11.4 Financial Overview
15.11.5 SWOT Analysis
15.11.6 Key Developments
15.12 Teva Pharmaceutical Industries Ltd
15.12.1 Key Facts
15.12.2 Business Description
15.12.3 Products and Services
15.12.4 Financial Overview
15.12.5 SWOT Analysis
15.12.6 Key Developments
16. Appendix
16.1 About The Insight Partners
16.2 Glossary of Terms
List of Tables
Table 1. Prescription Drugs Market Segmentation
Table 2. Key Brands Facing Patent Expirations
Table 3. North America: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Product Type
Table 4. North America: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Product Type
Table 5. North America: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Drug Type
Table 6. North America: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Drug Type
Table 7. North America: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Therapeutic Area
Table 8. North America: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Therapeutic Area
Table 9. North America: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Route Of Administration
Table 10. North America: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Route Of Administration
Table 11. North America: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Distribution Channel
Table 12. North America: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Distribution Channel
Table 13. United States: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Product Type
Table 14. United States: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Product Type
Table 15. United States: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Drug Type
Table 16. United States: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Drug Type
Table 17. United States: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Therapeutic Area
Table 18. United States: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Therapeutic Area
Table 19. United States: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Route Of Administration
Table 20. United States: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Route Of Administration
Table 21. United States: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Distribution Channel
Table 22. United States: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Distribution Channel
Table 23. Canada: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Product Type
Table 24. Canada: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Product Type
Table 25. Canada: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Drug Type
Table 26. Canada: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Drug Type
Table 27. Canada: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Therapeutic Area
Table 28. Canada: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Therapeutic Area
Table 29. Canada: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Route Of Administration
Table 30. Canada: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Route Of Administration
Table 31. Canada: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Distribution Channel
Table 32. Canada: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Distribution Channel
Table 33. Mexico: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Product Type
Table 34. Mexico: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Product Type
Table 35. Mexico: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Drug Type
Table 36. Mexico: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Drug Type
Table 37. Mexico: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Therapeutic Area
Table 38. Mexico: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Therapeutic Area
Table 39. Mexico: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Route Of Administration
Table 40. Mexico: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Route Of Administration
Table 41. Mexico: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Distribution Channel
Table 42. Mexico: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Distribution Channel
Table 43. Europe: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Product Type
Table 44. Europe: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Product Type
Table 45. Europe: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Drug Type
Table 46. Europe: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Drug Type
Table 47. Europe: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Therapeutic Area
Table 48. Europe: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Therapeutic Area
Table 49. Europe: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Route Of Administration
Table 50. Europe: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Route Of Administration
Table 51. Europe: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Distribution Channel
Table 52. Europe: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Distribution Channel
Table 53. Germany: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Product Type
Table 54. Germany: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Product Type
Table 55. Germany: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Drug Type
Table 56. Germany: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Drug Type
Table 57. Germany: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Therapeutic Area
Table 58. Germany: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Therapeutic Area
Table 59. Germany: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Route Of Administration
Table 60. Germany: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Route Of Administration
Table 61. Germany: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Distribution Channel
Table 62. Germany: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Distribution Channel
Table 63. United Kingdom: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Product Type
Table 64. United Kingdom: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Product Type
Table 65. United Kingdom: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Drug Type
Table 66. United Kingdom: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Drug Type
Table 67. United Kingdom: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Therapeutic Area
Table 68. United Kingdom: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Therapeutic Area
Table 69. United Kingdom: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Route Of Administration
Table 70. United Kingdom: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Route Of Administration
Table 71. United Kingdom: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Distribution Channel
Table 72. United Kingdom: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Distribution Channel
Table 73. France: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Product Type
Table 74. France: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Product Type
Table 75. France: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Drug Type
Table 76. France: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Drug Type
Table 77. France: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Therapeutic Area
Table 78. France: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Therapeutic Area
Table 79. France: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Route Of Administration
Table 80. France: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Route Of Administration
Table 81. France: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Distribution Channel
Table 82. France: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Distribution Channel
Table 83. Italy: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Product Type
Table 84. Italy: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Product Type
Table 85. Italy: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Drug Type
Table 86. Italy: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Drug Type
Table 87. Italy: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Therapeutic Area
Table 88. Italy: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Therapeutic Area
Table 89. Italy: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Route Of Administration
Table 90. Italy: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Route Of Administration
Table 91. Italy: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Distribution Channel
Table 92. Italy: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Distribution Channel
Table 93. Spain: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Product Type
Table 94. Spain: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Product Type
Table 95. Spain: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Drug Type
Table 96. Spain: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Drug Type
Table 97. Spain: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Therapeutic Area
Table 98. Spain: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Therapeutic Area
Table 99. Spain: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Route Of Administration
Table 100. Spain: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Route Of Administration
Table 101. Spain: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Distribution Channel
Table 102. Spain: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Distribution Channel
Table 103. Rest of Europe: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Product Type
Table 104. Rest of Europe: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Product Type
Table 105. Rest of Europe: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Drug Type
Table 106. Rest of Europe: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Drug Type
Table 107. Rest of Europe: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Therapeutic Area
Table 108. Rest of Europe: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Therapeutic Area
Table 109. Rest of Europe: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Route Of Administration
Table 110. Rest of Europe: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Route Of Administration
Table 111. Rest of Europe: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Distribution Channel
Table 112. Rest of Europe: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Distribution Channel
Table 113. Asia Pacific: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Product Type
Table 114. Asia Pacific: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Product Type
Table 115. Asia Pacific: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Drug Type
Table 116. Asia Pacific: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Drug Type
Table 117. Asia Pacific: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Therapeutic Area
Table 118. Asia Pacific: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Therapeutic Area
Table 119. Asia Pacific: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Route Of Administration
Table 120. Asia Pacific: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Route Of Administration
Table 121. Asia Pacific: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Distribution Channel
Table 122. Asia Pacific: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Distribution Channel
Table 123. China: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Product Type
Table 124. China: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Product Type
Table 125. China: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Drug Type
Table 126. China: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Drug Type
Table 127. China: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Therapeutic Area
Table 128. China: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Therapeutic Area
Table 129. China: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Route Of Administration
Table 130. China: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Route Of Administration
Table 131. China: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Distribution Channel
Table 132. China: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Distribution Channel
Table 133. Japan: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Product Type
Table 134. Japan: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Product Type
Table 135. Japan: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Drug Type
Table 136. Japan: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Drug Type
Table 137. Japan: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Therapeutic Area
Table 138. Japan: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Therapeutic Area
Table 139. Japan: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Route Of Administration
Table 140. Japan: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Route Of Administration
Table 141. Japan: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Distribution Channel
Table 142. Japan: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Distribution Channel
Table 143. India: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Product Type
Table 144. India: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Product Type
Table 145. India: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Drug Type
Table 146. India: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Drug Type
Table 147. India: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Therapeutic Area
Table 148. India: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Therapeutic Area
Table 149. India: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Route Of Administration
Table 150. India: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Route Of Administration
Table 151. India: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Distribution Channel
Table 152. India: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Distribution Channel
Table 153. Australia: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Product Type
Table 154. Australia: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Product Type
Table 155. Australia: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Drug Type
Table 156. Australia: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Drug Type
Table 157. Australia: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Therapeutic Area
Table 158. Australia: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Therapeutic Area
Table 159. Australia: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Route Of Administration
Table 160. Australia: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Route Of Administration
Table 161. Australia: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Distribution Channel
Table 162. Australia: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Distribution Channel
Table 163. South Korea: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Product Type
Table 164. South Korea: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Product Type
Table 165. South Korea: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Drug Type
Table 166. South Korea: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Drug Type
Table 167. South Korea: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Therapeutic Area
Table 168. South Korea: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Therapeutic Area
Table 169. South Korea: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Route Of Administration
Table 170. South Korea: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Route Of Administration
Table 171. South Korea: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Distribution Channel
Table 172. South Korea: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Distribution Channel
Table 173. Rest of APAC: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Product Type
Table 174. Rest of APAC: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Product Type
Table 175. Rest of APAC: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Drug Type
Table 176. Rest of APAC: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Drug Type
Table 177. Rest of APAC: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Therapeutic Area
Table 178. Rest of APAC: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Therapeutic Area
Table 179. Rest of APAC: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Route Of Administration
Table 180. Rest of APAC: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Route Of Administration
Table 181. Rest of APAC: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Distribution Channel
Table 182. Rest of APAC: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Distribution Channel
Table 183. Middle East and Africa: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Product Type
Table 184. Middle East and Africa: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Product Type
Table 185. Middle East and Africa: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Drug Type
Table 186. Middle East and Africa: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Drug Type
Table 187. Middle East and Africa: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Therapeutic Area
Table 188. Middle East and Africa: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Therapeutic Area
Table 189. Middle East and Africa: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Route Of Administration
Table 190. Middle East and Africa: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Route Of Administration
Table 191. Middle East and Africa: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Distribution Channel
Table 192. Middle East and Africa: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Distribution Channel
Table 193. Saudi Arabia: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Product Type
Table 194. Saudi Arabia: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Product Type
Table 195. Saudi Arabia: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Drug Type
Table 196. Saudi Arabia: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Drug Type
Table 197. Saudi Arabia: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Therapeutic Area
Table 198. Saudi Arabia: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Therapeutic Area
Table 199. Saudi Arabia: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Route Of Administration
Table 200. Saudi Arabia: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Route Of Administration
Table 201. Saudi Arabia: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Distribution Channel
Table 202. Saudi Arabia: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Distribution Channel
Table 203. South Africa: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Product Type
Table 204. South Africa: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Product Type
Table 205. South Africa: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Drug Type
Table 206. South Africa: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Drug Type
Table 207. South Africa: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Therapeutic Area
Table 208. South Africa: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Therapeutic Area
Table 209. South Africa: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Route Of Administration
Table 210. South Africa: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Route Of Administration
Table 211. South Africa: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Distribution Channel
Table 212. South Africa: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Distribution Channel
Table 213. United Arab Emirates: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Product Type
Table 214. United Arab Emirates: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Product Type
Table 215. United Arab Emirates: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Drug Type
Table 216. United Arab Emirates: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Drug Type
Table 217. United Arab Emirates: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Therapeutic Area
Table 218. United Arab Emirates: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Therapeutic Area
Table 219. United Arab Emirates: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Route Of Administration
Table 220. United Arab Emirates: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Route Of Administration
Table 221. United Arab Emirates: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Distribution Channel
Table 222. United Arab Emirates: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Distribution Channel
Table 223. Rest of Middle East and Africa: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Product Type
Table 224. Rest of Middle East and Africa: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Product Type
Table 225. Rest of Middle East and Africa: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Drug Type
Table 226. Rest of Middle East and Africa: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Drug Type
Table 227. Rest of Middle East and Africa: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Therapeutic Area
Table 228. Rest of Middle East and Africa: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Therapeutic Area
Table 229. Rest of Middle East and Africa: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Route Of Administration
Table 230. Rest of Middle East and Africa: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Route Of Administration
Table 231. Rest of Middle East and Africa: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Distribution Channel
Table 232. Rest of Middle East and Africa: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Distribution Channel
Table 233. South and Central America: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Product Type
Table 234. South and Central America: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Product Type
Table 235. South and Central America: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Drug Type
Table 236. South and Central America: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Drug Type
Table 237. South and Central America: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Therapeutic Area
Table 238. South and Central America: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Therapeutic Area
Table 239. South and Central America: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Route Of Administration
Table 240. South and Central America: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Route Of Administration
Table 241. South and Central America: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Distribution Channel
Table 242. South and Central America: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Distribution Channel
Table 243. Brazil: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Product Type
Table 244. Brazil: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Product Type
Table 245. Brazil: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Drug Type
Table 246. Brazil: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Drug Type
Table 247. Brazil: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Therapeutic Area
Table 248. Brazil: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Therapeutic Area
Table 249. Brazil: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Route Of Administration
Table 250. Brazil: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Route Of Administration
Table 251. Brazil: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Distribution Channel
Table 252. Brazil: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Distribution Channel
Table 253. Argentina: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Product Type
Table 254. Argentina: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Product Type
Table 255. Argentina: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Drug Type
Table 256. Argentina: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Drug Type
Table 257. Argentina: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Therapeutic Area
Table 258. Argentina: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Therapeutic Area
Table 259. Argentina: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Route Of Administration
Table 260. Argentina: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Route Of Administration
Table 261. Argentina: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Distribution Channel
Table 262. Argentina: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Distribution Channel
Table 263. Rest of South and Central America: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Product Type
Table 264. Rest of South and Central America: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Product Type
Table 265. Rest of South and Central America: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Drug Type
Table 266. Rest of South and Central America: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Drug Type
Table 267. Rest of South and Central America: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Therapeutic Area
Table 268. Rest of South and Central America: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Therapeutic Area
Table 269. Rest of South and Central America: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Route Of Administration
Table 270. Rest of South and Central America: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Route Of Administration
Table 271. Rest of South and Central America: Prescription Drugs Market – Revenue, 2021–2024 (US$ Billion) – by Distribution Channel
Table 272. Rest of South and Central America: Prescription Drugs Market – Revenue Forecast, 2025–2031 (US$ Billion) – by Distribution Channel
Table 273. Heat Map Analysis by Key Players
Table 274. Recent Organic Growth Strategies in the Prescription Drugs Market
Table 275. Recent Inorganic Growth Strategies in the Prescription Drugs Market
Table 276. Glossary of Terms, Medical Cables Market
List of Figures
Figure 1. Prescription Drugs Market Segmentation, by Geography
Figure 2. PEST Analysis
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Prescription Drugs Market Revenue (US$ Billion), 2021–2031
Figure 5. Prescription Drugs Market Revenue (US$ Billion) Forecast Analysis, 2021–2031
Figure 6. Prescription Drugs Market Share (%) – by Product Type (2024 and 2031)
Figure 7. Branded: Prescription Drugs Market – Revenue and Forecast to 2031 (US$ Billion)
Figure 8. Generics: Prescription Drugs Market – Revenue and Forecast to 2031 (US$ Billion)
Figure 9. Prescription Drugs Market Share (%) – by Drug Type (2024 and 2031)
Figure 10. Small Molecule: Prescription Drugs Market – Revenue and Forecast to 2031 (US$ Billion)
Figure 11. Biologics and Biosimilar: Prescription Drugs Market – Revenue and Forecast to 2031 (US$ Billion)
Figure 12. Prescription Drugs Market Share (%) – by Therapeutic Area (2024 and 2031)
Figure 13. Oncology: Prescription Drugs Market – Revenue and Forecast to 2031 (US$ Billion)
Figure 14. Cardiovascular Diseases: Prescription Drugs Market – Revenue and Forecast to 2031 (US$ Billion)
Figure 15. Neurological Diseases: Prescription Drugs Market – Revenue and Forecast to 2031 (US$ Billion)
Figure 16. Metabolic Diseases: Prescription Drugs Market – Revenue and Forecast to 2031 (US$ Billion)
Figure 17. Respiratory Diseases: Prescription Drugs Market – Revenue and Forecast to 2031 (US$ Billion)
Figure 18. Immunology: Prescription Drugs Market – Revenue and Forecast to 2031 (US$ Billion)
Figure 19. Others: Prescription Drugs Market – Revenue and Forecast to 2031 (US$ Billion)
Figure 20. Prescription Drugs Market Share (%) – by Route Of Administration (2024 and 2031)
Figure 21. Oral: Prescription Drugs Market – Revenue and Forecast to 2031 (US$ Billion)
Figure 22. Injectable: Prescription Drugs Market – Revenue and Forecast to 2031 (US$ Billion)
Figure 23. Topical: Prescription Drugs Market – Revenue and Forecast to 2031 (US$ Billion)
Figure 24. Others: Prescription Drugs Market – Revenue and Forecast to 2031 (US$ Billion)
Figure 25. Prescription Drugs Market Share (%) – by Distribution Channel (2024 and 2031)
Figure 26. Hospital Pharmacies: Prescription Drugs Market – Revenue and Forecast to 2031 (US$ Billion)
Figure 27. Retail Pharmacies: Prescription Drugs Market – Revenue and Forecast to 2031 (US$ Billion)
Figure 28. Online Pharmacies: Prescription Drugs Market – Revenue and Forecast to 2031 (US$ Billion)
Figure 29. North America: Prescription Drugs Market – Revenue, 2021–2031 (US$ Billion)
Figure 30. North America: Prescription Drugs Market Breakdown, by Key Countries, 2024 and 2031 (%)
Figure 31. United States: Prescription Drugs Market – Revenue and Forecast, 2021–2031 (US$ Billion)
Figure 32. Canada: Prescription Drugs Market – Revenue and Forecast, 2021–2031 (US$ Billion)
Figure 33. Mexico: Prescription Drugs Market – Revenue and Forecast, 2021–2031 (US$ Billion)
Figure 34. Europe: Prescription Drugs Market – Revenue, 2021–2031 (US$ Billion)
Figure 35. Europe: Prescription Drugs Market Breakdown, by Key Countries, 2024 and 2031 (%)
Figure 36. Germany: Prescription Drugs Market – Revenue and Forecast, 2021–2031 (US$ Billion)
Figure 37. United Kingdom: Prescription Drugs Market – Revenue and Forecast, 2021–2031 (US$ Billion)
Figure 38. France: Prescription Drugs Market – Revenue and Forecast, 2021–2031 (US$ Billion)
Figure 39. Italy: Prescription Drugs Market – Revenue and Forecast, 2021–2031 (US$ Billion)
Figure 40. Spain: Prescription Drugs Market – Revenue and Forecast, 2021–2031 (US$ Billion)
Figure 41. Rest of Europe: Prescription Drugs Market – Revenue and Forecast, 2021–2031 (US$ Billion)
Figure 42. Asia Pacific: Prescription Drugs Market – Revenue, 2021–2031 (US$ Billion)
Figure 43. Asia Pacific: Prescription Drugs Market Breakdown, by Key Countries, 2024 and 2031 (%)
Figure 44. China: Prescription Drugs Market – Revenue and Forecast, 2021–2031 (US$ Billion)
Figure 45. Japan: Prescription Drugs Market – Revenue and Forecast, 2021–2031 (US$ Billion)
Figure 46. India: Prescription Drugs Market – Revenue and Forecast, 2021–2031 (US$ Billion)
Figure 47. Australia: Prescription Drugs Market – Revenue and Forecast, 2021–2031 (US$ Billion)
Figure 48. South Korea: Prescription Drugs Market – Revenue and Forecast, 2021–2031 (US$ Billion)
Figure 49. Rest of APAC: Prescription Drugs Market – Revenue and Forecast, 2021–2031 (US$ Billion)
Figure 50. Middle East and Africa: Prescription Drugs Market – Revenue, 2021–2031 (US$ Billion)
Figure 51. Middle East and Africa: Prescription Drugs Market Breakdown, by Key Countries, 2024 and 2031 (%)
Figure 52. Saudi Arabia: Prescription Drugs Market – Revenue and Forecast, 2021–2031 (US$ Billion)
Figure 53. South Africa: Prescription Drugs Market – Revenue and Forecast, 2021–2031 (US$ Billion)
Figure 54. United Arab Emirates: Prescription Drugs Market – Revenue and Forecast, 2021–2031 (US$ Billion)
Figure 55. Rest of Middle East and Africa: Prescription Drugs Market – Revenue and Forecast, 2021–2031 (US$ Billion)
Figure 56. South and Central America: Prescription Drugs Market – Revenue, 2021–2031 (US$ Billion)
Figure 57. South and Central America: Prescription Drugs Market Breakdown, by Key Countries, 2024 and 2031 (%)
Figure 58. Brazil: Prescription Drugs Market – Revenue and Forecast, 2021–2031 (US$ Billion)
Figure 59. Argentina: Prescription Drugs Market – Revenue and Forecast, 2021–2031 (US$ Billion)
Figure 60. Rest of South and Central America: Prescription Drugs Market – Revenue and Forecast, 2021–2031 (US$ Billion)
Figure 61. Company Positioning & Concentration
Figure 62. Growth Strategies in the Prescription Drugs Market
The List of Companies - Prescription Drugs Market
- Johnson & Johnson
- Pfizer Inc
- Merck & Co Inc
- Eli Lilly and Co
- ESTEVE
- AstraZeneca Plc
- Sanofi SA
- GSK Plc
- F. Hoffmann-La Roche
- Novartis AG
- AbbVie Inc
- Teva Pharmaceutical Industries Ltd
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For